Bilbo Patrick 4
4 · Organogenesis Holdings Inc. · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Bilbo Patrick
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-21+338,674→ 338,674 totalExercise: $3.43Exp: 2034-02-21→ Class A Common Stock (338,674 underlying) - Award
Class A Common Stock
2024-02-21+187,318→ 659,329 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2024.
- [F2]The option becomes exercisable in equal annual installments over four years beginning February 15, 2024.